MARKET

LLY

LLY

Lilly Eli & Co
NYSE
1,074.68
-5.07
-0.47%
After Hours: 1075.17 +0.49 +0.05% 19:59 12/31 EST
OPEN
1,079.76
PREV CLOSE
1,079.75
HIGH
1,083.50
LOW
1,074.43
VOLUME
1.65M
TURNOVER
--
52 WEEK HIGH
1,111.99
52 WEEK LOW
621.50
MARKET CAP
1.02T
P/E (TTM)
52.55
1D
5D
1M
3M
1Y
5Y
1D
Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy.
The Motley Fool · 1h ago
Wall Street Lunch: Craft Beers Enter 2026 On Choppy Waters
Seeking Alpha · 12/31/2025 20:20
In the Year of the Weight-Loss Pill, Lilly Still Leads GLP-1s
Barron‘s · 12/31/2025 20:08
All J.P. Morgan's top stock picks for 2026
Seeking Alpha · 12/31/2025 17:44
Could This Potential Move Boost Eli Lilly's Prospects?
The Motley Fool · 12/31/2025 16:20
Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval
Barron‘s · 12/31/2025 15:57
Pfizer (PFE) Tops List as Drugmakers Plan Price Hike on 350 Medications
TipRanks · 12/31/2025 15:02
Drugmakers Plan Fresh Price Hikes On 350 Medicines In 2026
Benzinga · 12/31/2025 13:59
More
About LLY
Eli Lilly and Company is a medicine company, which discovers, develops, manufactures, markets, and sells pharmaceutical products worldwide. Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company is also engaged in radiopharmaceutical discovery, development, and manufacturing efforts, and clinical and pre-clinical radioligand therapies in development for the treatment of cancer. It is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD). It is evaluating its novel gene therapy candidate, ixoberogene soroparvovec.

Webull offers Eli Lilly And Co stock information, including NYSE: LLY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LLY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LLY stock methods without spending real money on the virtual paper trading platform.